Incidence of cachexia in patients with advanced gastrointestinal cancer at the beginning of rehabilitation intervention.
Activities of daily living
Gastrointestinal cancer
Rehabilitation
Journal
Journal of physical therapy science
ISSN: 0915-5287
Titre abrégé: J Phys Ther Sci
Pays: Japan
ID NLM: 9105359
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
received:
23
07
2019
accepted:
17
10
2019
entrez:
22
2
2020
pubmed:
23
2
2020
medline:
23
2
2020
Statut:
ppublish
Résumé
[Purpose] We examined the incidence of cachexia at the beginning of rehabilitation in patients with advanced gastrointestinal cancer. [Participants and Methods] Patients with gastrointestinal cancer who were prescribed physical therapy and occupational therapy by their rehabilitation doctor and completed the survey item were targeted. We administered the cancer cachexia assessment and evaluated activities of daily living, and nutritional status in all participants. [Results] There were 15 patients in the normal group, 8 in the normal low-nutrition group, 16 in the pre-cachexia group, and 57 in the cachexia group. The cachexia group showed significantly lower nutritional status, and were less able to perform activities of daily living than the normal and pre-cachexia groups. [Conclusion] The incidence of cachexia among study participants was 17% in the pre-cachexia group and 59% in the cachexia group at the beginning of rehabilitation. Patients with advanced gastrointestinal cancer may have a higher incidence of cachexia at the beginning of rehabilitation.
Identifiants
pubmed: 32082021
doi: 10.1589/jpts.32.16
pii: jpts-2019-174
pmc: PMC7008023
doi:
Types de publication
Journal Article
Langues
eng
Pagination
16-19Informations de copyright
2020©by the Society of Physical Therapy Science. Published by IPEC Inc.
Déclaration de conflit d'intérêts
The authors have no conflict of interests to declare in regards to this research.
Références
Med Res Rev. 1997 Sep;17(5):477-98
pubmed: 9276862
Acta Oncol. 2009;48(1):116-24
pubmed: 18607877
Am J Epidemiol. 2002 Jul 15;156(2):110-21
pubmed: 12117699
CA Cancer J Clin. 2002 Mar-Apr;52(2):72-91
pubmed: 11929007
Physiol Rev. 2009 Apr;89(2):381-410
pubmed: 19342610
J Natl Cancer Inst. 1997 Dec 3;89(23):1763-73
pubmed: 9392617
J Surg Oncol. 2008 Dec 1;98(7):540-4
pubmed: 18937231
Nat Rev Cancer. 2002 Nov;2(11):862-71
pubmed: 12415256
J Am Geriatr Soc. 2002 May;50(5):897-904
pubmed: 12028178
Am J Physiol Regul Integr Comp Physiol. 2011 Feb;300(2):R201-11
pubmed: 21148472
Lancet Oncol. 2011 May;12(5):489-95
pubmed: 21296615
Curr Treat Options Oncol. 2010 Dec;11(3-4):107-17
pubmed: 21128029
Clin Cancer Res. 2007 Nov 1;13(21):6379-85
pubmed: 17975150
Best Pract Res Clin Endocrinol Metab. 2008 Oct;22(5):813-29
pubmed: 19028358
Br J Cancer. 1997;75(1):106-9
pubmed: 9000606
J Gerontol A Biol Sci Med Sci. 2001 Oct;56(10):B443-8
pubmed: 11584029
Int J Cardiol. 2002 Sep;85(1):73-81
pubmed: 12163211
BMC Cancer. 2010 Jul 08;10:363
pubmed: 20615237